FAST:NASDAQFastenal Company Analysis
Data as of 2026-05-27 - not real-time
$44.45
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Fastenal is trading at a steep premium with a trailing P/E of 39.3 versus an industry average of 30.1, and a DCF‑derived fair value of only $17.1 compared to the current price of $44.45. The stock shows a neutral technical stance – the 20‑day SMA (44.07) sits just below price, the 50‑day SMA (45.01) above, and the MACD line is marginally bullish, while volume is trending down and the RSI hovers around 51, indicating limited short‑term momentum. Recent analyst sentiment turned mildly positive as Baird lifted its price target to $51 and reaffirmed an Outperform rating, suggesting some upside potential despite the valuation gap.
Fundamentally, FAST delivers robust growth with 12.4% revenue expansion, high profitability (operating margin 20.3%, ROE 33.8%), and a solid free cash flow generation that comfortably supports its 2.07% dividend yield, albeit at a high payout ratio of 80%. The company’s low beta (0.65) and defensive industrial distribution franchise keep sector and regulatory risks modest, though the elevated volatility (≈22% 30‑day) and decreasing volume introduce medium‑level liquidity concerns. Overall, the balance of strong cash generation and dividend income favors a hold‑to‑buy stance for medium‑term investors, while short‑term positioning remains cautious pending price confirmation.
Fundamentally, FAST delivers robust growth with 12.4% revenue expansion, high profitability (operating margin 20.3%, ROE 33.8%), and a solid free cash flow generation that comfortably supports its 2.07% dividend yield, albeit at a high payout ratio of 80%. The company’s low beta (0.65) and defensive industrial distribution franchise keep sector and regulatory risks modest, though the elevated volatility (≈22% 30‑day) and decreasing volume introduce medium‑level liquidity concerns. Overall, the balance of strong cash generation and dividend income favors a hold‑to‑buy stance for medium‑term investors, while short‑term positioning remains cautious pending price confirmation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD crossover but price near support
- Decreasing volume indicating weaker momentum
- RSI near neutral suggesting limited upside
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong earnings growth and high ROE
- Attractive dividend yield with solid cash flow
- Analyst target price upside of ~5% to $45‑$51
Long Term
> 3 yearsNeutral
Model confidence: 8/10
Key Factors
- Durable industrial distribution franchise
- Consistent dividend payments and cash generation
- Valuation premium may limit total return
Key Metrics & Analysis
Financial Health
Revenue Growth12.40%
Profit Margin15.39%
P/E Ratio39.3
ROE33.84%
ROA21.20%
Debt/Equity11.17
P/B Ratio12.8
Op. Cash Flow$1.4B
Free Cash Flow$903.9M
Industry P/E30.1
Technical Analysis
TrendNeutral
RSI50.8
Support$42.91
Resistance$45.64
MA 20$44.07
MA 50$45.01
MA 200$44.70
MACDBullish
VolumeDecreasing
Fear & Greed Index91.43
Valuation
Fair Value$17.13
Target Price$46.63
Upside/Downside4.90%
GradeOvervalued
TypeGrowth
Dividend Yield2.07%
Risk Assessment
Beta0.65
Volatility21.86%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.